Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Arbutus Biopharma Corporation an industry-leading therapeutic solutions company focused on developing a cure for chronic hepatitis B virus (HBV) infection, announced that the Supreme Court of British Columbia granted Arbutus’ request for a pre-trial injunction against Acuitas, preventing Acuitas from sublicensing Arbutus’ lipid nanoparticle (LNP) technology until the end of October, or further order of the Court.  Under the terms of the pre-trial injunction, Acuitas is prevented from entering into any new agreements which include sublicensing of Arbutus’ LNP.

  • Investments and innovations in R & D activities are pushing market players to launch manufacturing projects in environmentally friendly and biodegradable packaging, which are expected to increase in the near future . In addition, the expiration of patents for various drug drugs should feed the pharmaceutical packaging market during the forecast period.

  • New research estimates that Global counterfeiting and piracy will continue to grow at a shocking rate over the next five years, hitting a level of $1.9trn to $2.8trn by 2022.

    The report builds on findings of an often-cited Organization for Economic Cooperation and Development (OECD) and European Union Intellectual Property Office (EUIPO) report, which estimated that trade in counterfeit and pirated products accounted for as much as 2.5 per cent of global trade in 2013.

  • President Trump promised to review the Food and Drug Administration could make major changes, including steps to accelerate the approval process of new prescription drugs, setting up a shock with critics who say its push for the Deregulation could put consumers at risk.

  • In response to a written question in Rajya Sabha, Minister of State for Health Faggan Singh Kulaste stated that a subcommittee formed to consider issues related to online drug sales presented its recommendations suggesting the creation of a national portal to monitor such sales as well as certain restrictions imposed on them.

  • Antibiotic resistance is the result of environmental and behavioral causes. Indiscriminate antibiotic prescribing and lax enforcement laws are the main causes of antimicrobial resistance. This may be due to reckless use of antibiotics in hospitals as well as in private practice outside the easy availability of prescription drugs in the country.

Subscribe to Pharma News